Interventional Neurology Market 2021: Global Industry Share, Demand, Revenue, Size, Trends, Development, Opportunity, Growth Factors, Gross Margin, Major Companies, Value Chain, and 2028 Forecast
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Interventional Neurology Market 2021: Global Industry Share, Demand, Revenue, Size, Trends, Development, Opportunity, Growth Factors, Gross Margin, Major Companies, Value Chain, and 2028 Forecast
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
/Neurothrombectomy segment of Neurointerventional Devices Market is expected to grow with a CAGR of 8.0% at a fast pace to reach US$ 4,524.34 Mn over the forecast period from 2021-2027 | Merit Medical Systems, Penumbra, Inc., Rapid Medical, and InspireMD, Inc.
Neurothrombectomy segment of Neurointerventional Devices Market is expected to grow with a CAGR of 8.0% at a fast pace to reach US$ 4,524.34 Mn over the forecast period from 2021-2027 | Merit Medical Systems, Penumbra, Inc., Rapid Medical, and InspireMD, Inc.
tipMay 14, 2021 1
The global neurointerventional devices market is anticipated to reach US$ 4,524.34 Mn in 2027 from US$ 2,323.02 Mn in 2018. The market is anticipated to grow with a CAGR of 8.0% from 2020-2027.
The microspheres subsegment of embolic agents products to hold major market share by 2026
Based on product, the market is further segmented into embolization coils (detachable coils and pushable coils), embolic agents (liquid embolic agents and microspheres), detachable balloons, embolic plug systems, and support devices (microcatheters and guidewires). The microspheres subsegment of embolic agent products commanded the largest share of the embolotherapy market in 2020 and the trend is expected to continue by 2026. Market growth is driven by the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies. Moreover, new product launches and approvals are further supporting the growth of the segment.